Link's Take On The ...
Health Care: Drugs
Neurocrine Biosciences Inc. (NBIX: NASDAQ)
$12.88 0.18 | 1.42%
06/19/13 - 04:00 PM ET
707.22K / 564.30K
Vol / Avg. Vol:12.82 / 12.70
Open / Prev. Close:12.82 - 13.35
Today's Range:6.72 - 14.06
52 Wk Range:70.05%
Performance YTD:TheStreet Rating:
Portfolios with NBIX
- Portfolio NameUser Type
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks With Big Insider Buy...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor5 Drug Stock Winners of 2010
- UserKareem Portfolio
- UserSUPRATRADE Top 10 Micro Cap...
- UserBVF Inc.
- UserRAPTOR SPRTD-1110080822
- UserDblD01
- Userburrex Portfolio 1
Latest NBIX Headlines from TheStreet
- Neurocrine Biosciences Inc. Stock Upgraded (NBIX) 02.12.13 | 04:02 am
- Neurocrine Biosciences Inc. Stock Downgraded (NBIX) 11.07.12 | 04:11 am
- Neurocrine Biosciences' Management Presents At Morgan Stanley Global Healthcare Conference - Transcript 09.12.12 | 12:09 pm
- Neurocrine Biosciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 09:07 pm
- Neurocrine Biosciences' CEO Presents At Deutsche Bank 37th Annual Health Care Conference (Transcript) 05.09.12 | 05:05 pm
- Neurocrine Biosciences' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 08:05 pm
- Neurocrine Biosciences' CEO Reviews Phase II Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia (Transcript) 03.27.12 | 01:03 pm
- Neurocrine Stock Falls On Unusually High Volume (NBIX) 03.27.12 | 12:03 pm
- Apollo Group, Neurocrine: After-Hours Trading 03.26.12 | 05:03 pm
- Neurocrine Biosciences' CEO Presents At 30th Annual JPMorgan Global Healthcare Conference - Conference Call Transcript 03.09.12 | 05:03 pm
Press Releases for NBIX
- Neurocrine Biosciences To Present At The Jefferies 2013 Global Healthcare Conference - PR Newswire 05.29.13 | 05:05 pm
- Neurocrine Biosciences To Present At The Deutsche Bank 38th Annual DbAccess Health Care Conference - PR Newswire 05.23.13 | 05:05 pm
- Neurocrine Biosciences To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference - PR Newswire 05.09.13 | 03:05 pm
- Neurocrine Biosciences Announces Conference Call And Webcast To Present First Quarter 2013 Financial Results - PR Newswire 04.26.13 | 01:04 pm
- Neurocrine Biosciences To Present At The Needham 12th Annual Healthcare Conference - PR Newswire 04.24.13 | 01:04 pm
- Neurocrine Biosciences Announces The Start Of Phase IIb Study Of Elagolix In Uterine Fibroids - PR Newswire 03.27.13 | 07:03 am
- Neurocrine Biosciences To Present At The 25th Annual Roth Conference - PR Newswire 03.11.13 | 11:03 am
- Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.27.13 | 11:02 am
- Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013 - PR Newswire 02.06.13 | 11:02 am
- Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results - PR Newswire 02.01.13 | 03:02 pm
Partner Headlines for NBIX
- Healthcare Biz Recap: Complete Genomics CUTS Costs, Abbott Labs Teams Up - Wall St. Cheat Sheet 06.06.12 | 08:06 am
- 10 Small-Cap Stocks With Strong Profitability And Plenty Of Cash On Hand - Seeking Alpha 11.04.11 | 08:11 am
- Neurocrine Biosciences (NBIX) - Bull of the Day - Zacks 11.02.11 | 01:11 am
- 10 Overvalued Healthcare Stocks - Seeking Alpha 10.25.11 | 08:10 am
- Insider Buying And A Pending Catalyst Send Neurocrine Bioscience's Shares Higher - Seeking Alpha 10.17.11 | 07:10 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Piper Jaffray Maintains Overweight on Neurocrine Biosciences (NBIX) - Benzinga 03.25.11 | 09:03 am
- Unconfirmed Rumors Circulate that Neurocrine Biosciences Inc. (NBIX) will be taken out by Eli Lilly & Co. (LLY) at $17.00 a share - Benzinga 12.22.10 | 09:12 am
- Bullish on Neurocrine Bio After Latest Clinical Trials - Seeking Alpha 12.08.10 | 08:12 am
- Best Performing Stocks Year to Date - Seeking Alpha 11.01.10 | 09:11 am
